Findcure Biosciences (zhongshan) Co., Ltd.

This study tests a new pill (FC084CSA) combined with an immunotherapy (tislelizumab) in people with advanced solid tumors that haven't responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors or slow their growth. About 33…

This early-stage study tests a new radioactive tracer called 68Ga-FC516 for PET/CT scans. It includes 10 participants—healthy adults and prostate cancer patients—to check safety, how the tracer spreads in the body, and how well it spots tumors compared to existing tracers. The go…